
ACCORD
ACCORD is a seamless, Phase 2, adaptive, randomised controlled platform study, designed to rapidly test candidate agents in the treatment of COVID-19.

ACCORD is a seamless, Phase 2, adaptive, randomised controlled platform study, designed to rapidly test candidate agents in the treatment of COVID-19.

CLASP (Cancer: Life Affirming Survivorship support in Primary care Programme) aims to evaluate an online intervention offering lifestyle and wellbeing support for cancer survivors, called Renewed.

ENeRgy (Exercise and Nutritional Rehabilitation in patients with cancer) study will investigate whether an exercise and nutrition based rehabilitation programme is feasible in patients with advanced cancer.

TheÌýHOME-BP study aims to assess the effectiveness of aÌýdigital interventionÌýthe self-management of high blood pressure.

TheÌýPALS study aims to assess the effectiveness ofÌýa web-based social networking toolÌýto reduce the negative impacts of loneliness and social isolation.
.jpg)
NHS research into artificial intelligence in skin cancer care

RECON will investigate the use of a website called ‘Active Brains’ which aims preventing problems with memory, concentration and reasoning which may assist in slowing cognitive decline in older adults.